Biotech giant Bristol-Myers Squibb Company (BMY) is scheduled to report third-quarter 2024 results on Oct. 31, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $11.3 billion and $1.50 per share, respectively. | --- | --- | --- | --- | --- | |----------------------------------------------|-------|-------|-------|-------| | Magnitude Consensus Estimate Trend (60 Days) | Q1 | Q2 | F1 | F2 | | Current | 1.50 | 1.54 | 0.72 | 7.05 | | 7 Days Ago | 1.52 | 1.54 | 0.74 | 7.05 | | ...